• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Are Migraines Different in Women and Men?

Slideshow

Migraine headache (MHA) is a common neurologic disorder with prevalence greater among women than men in a 3:1 ratio. The difference is usually explained as being related to hormonal differences between the sexes. However, given that a significant number of men develop MHA, this explanation seems insufficient to fully explain the disproportionate ratio.

A new study that assessed the differences in experience of MHA between women and men also looked at MHA in women who were perimenstrual and nonperimenstrual. Click through the slides below for highlights of the findings.

Related Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
Untreated, New-Onset Hypertension Tied to Higher Risk of Uterine Fibroids in Women / Image credit: ©AGPhotography/AdobeStock

Untreated, New-Onset Hypertension Tied to Higher Risk of Uterine Fibroids in Women

April 19th 2024
Article

Women with new-onset HTN faced a 45% greater risk of newly self-reported fibroids and those with untreated HTN had a 19% greater risk, according to a new study.

Obesity & Pain Management: A Primary Viewpoints Podcast

Obesity & Pain Management: A Primary Viewpoints Podcast

April 27th 2023
Podcast

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Regulatory Submission / image credit obese man asleep / ©motortion/stock.adobe.com

Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Mid-2024 Regulatory Submission

April 17th 2024
Article

Tirzepatide reduced OSA symptoms and body weight in study participants with severe OSA and obesity, regardless of use of positive airway pressure therapy.

Distress Signals: How to Help a Clinician Colleague in Need

Distress Signals: How to Help a Clinician Colleague in Need

February 14th 2023
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

Primary Care-Based Injury Prevention Program Reduces Pediatric Injuries: Daily Dose / image credit: ©New Africa/AdobeStock

Primary Care-Based Injury Prevention Program Reduces Pediatric Injuries: Daily Dose

April 12th 2024
Article

Your daily dose of the clinical news you may have missed.

Consider CGRP Inhibitors as a First-Line Option for Preventive Treatment of Migraine: New American Headache Society Consensus Statement / image credit - headache: ©peterschreiber.media/stock.adobe.com

Consider CGRP Inhibitors as a First-Line Option for Preventive Treatment of Migraine: New American Headache Society Consensus Statement

April 12th 2024
Article

The AHS recommends the migraine-specific preventive medications be prescribed first, with no requirements to "fail" other treatments for eligibility.

© 2024 MJH Life Sciences

All rights reserved.